DHL starts global COVID vaccine distribution

DHL, the leading global brand in the logistics industry, has commenced the international distribution of the COVID-19 vaccine. 

For the provision of its citizens the Government of Israel received the first batch of the vaccine with flights operated by DHL Express and DHL Global Forwarding last week and was received by Prime Minister Benjamin Netanyahu. DHL Global Forwarding, the international freight specialist arm of Deutsche Post DHL Group, also dedicated a charter flight for additional supplies of vaccine doses, with more to follow. 

“After numerous month of preparation we are happy that our mission of vaccine distribution has now started and we could contribute our logistics expertise and capabilities to make vaccine accessible worldwide,” says DHL Express Head of Global Network Operations and Aviation Travis Cobb. “The current crisis has shown how indispensable international logistics networks are for ensuring that societies have the necessary personal protective equipment and test kits to secure their health. Now we are embarking on the next step in our common fight against the coronavirus. Our teams across 220 countries and territories and our global network as the backbone of cross-border Express logistics is ready – to deliver anytime and anywhere.”

“The development of a coronavirus vaccine is a silver lining and we are proud to play an active role as the most global logistics provider in bringing this silver lining to people. With our extensive logistics expertise in the Life Sciences and Healthcare sector paired with the commitment and passion of our people we want to play our part in making the corona pandemic history. That’s the purpose of Deutsche Post DHL Group – connecting people and improving lives,” states DHL Global Forwarding Head of Global Airfreight Thomas Mack.

DHL is now preparing to carry out further flights in December with vaccines from its worldwide operating hubs.

More than 9,000 specialists work across DHL’s dedicated global network so that pharmaceutical, medical devices, clinical trials and research organisations, wholesalers and distributors, as well as hospitals and healthcare providers are connected across the value chain and through digitalisation, from clinical trials to point of care, and every step in between.